Fangrong Yan

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 41

Top Topics

Renal Cell Carcinoma

Top Venues

Clinical trials (London, England)

Clinical and translational medicine

Statistical methods in medical research

Journal of biopharmaceutical statistics

This page only lists publications with an associated author ORCID identifier.

Publications

Jingyi Zhang, Ruitao Lin, Xin Chen, Fangrong Yan
Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses. Clinical trials (London, England) (2024)
Jingyi Zhang, Ruitao Lin, Xin Chen, Fangrong Yan
Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses. Clinical trials (London, England) 21 (3) (2024)
Jingyi Zhang, Ruitao Lin, Xin Chen, Fangrong Yan
Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses. Clinical trials (London, England) 21 (3) (2024)
Jingyi Zhang, Ruitao Lin, Xin Chen, Fangrong Yan
Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses. Clinical trials (London, England) 21 (3) (2024)
Jingyi Zhang, Ruitao Lin, Xin Chen, Fangrong Yan
Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses. Clinical trials (London, England) (2024)
Junkai Zhu, Yuyao Zhu, Xin Wang, Wenxuan Cheng, Shuaiyi Wang, Junluo Yang, Wenxuan Wang, Yuhang Wang, Jia-Lin Meng, Xiaofan Lu, Fangrong Yan
MOVICShiny: An interactive website for multi-omics integration and visualisation in cancer subtyping. Clinical and translational medicine 14 (3) (2024)
Junkai Zhu, Yuyao Zhu, Xin Wang, Wenxuan Cheng, Shuaiyi Wang, Junluo Yang, Wenxuan Wang, Yuhang Wang, Jia-Lin Meng, Xiaofan Lu, Fangrong Yan
MOVICShiny: An interactive website for multi-omics integration and visualisation in cancer subtyping. Clinical and translational medicine 14 (3) (2024)
Jingyi Zhang, Ruitao Lin, Xin Chen, Fangrong Yan
Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses. Clinical trials (London, England) 21 (3) (2024)
Junkai Zhu, Yuyao Zhu, Xin Wang, Wenxuan Cheng, Shuaiyi Wang, Junluo Yang, Wenxuan Wang, Yuhang Wang, Jia-Lin Meng, Xiaofan Lu, Fangrong Yan
MOVICShiny: An interactive website for multi-omics integration and visualisation in cancer subtyping. Clinical and translational medicine 14 (3) (2024)
Jia-Lin Meng, Aimin Jiang, Xiaofan Lu, Di Gu, Qintao Ge, Suwen Bai, Yundong Zhou, Jun Zhou, Zongyao Hao, Fangrong Yan, Linhui Wang, Haitao Wang, Juan Du, Chaozhao Liang
Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy. iMeta 2 (4) (2023)
Liwen Su, Xin Chen, Jingyi Zhang, Fangrong Yan
MIDAS-2: an enhanced Bayesian platform design for immunotherapy combinations with subgroup efficacy exploration. Journal of biopharmaceutical statistics (2023)
Xiaoping Su, Xiaofan Lu, Sehrish Khan Bazai, Linda Dainese, Arnauld Verschuur, Benoit Dumont, Roger Mouawad, Li Xu, Wenxuan Cheng, Fangrong Yan, Sabine Irtan, Véronique Lindner, Catherine Paillard, Yves Le Bouc, Aurore Coulomb, Gabriel G Malouf
Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors. Nature communications 14 (1) (2023)
Liyun Jiang, Peter F Thall, Fangrong Yan, Scott Kopetz, Ying Yuan
BASIC: A Bayesian adaptive synthetic-control design for phase II clinical trials. Clinical trials (London, England) (2023)
Xiaofan Lu, Nassim Tawanaie Pour Sedehi, Xiaoping Su, Fangrong Yan, Omar Alhalabi, Nizar M Tannir, Gabriel G Malouf
Racial Disparities in MiT Family Translocation Renal Cell Carcinoma. The oncologist (2023)
Jingyi Zhang, Xin Chen, Bosheng Li, Fangrong Yan
A comparative study of adaptive trial designs for dose optimization. Pharmaceutical statistics (2023)
Bosheng Li, Jingyi Zhang, Wenyi Yang, Liwen Su, Fangrong Yan
Group sequential design with maximin efficiency robust test for immunotherapy with generalized delayed treatment effect. Pharmaceutical statistics (2023)
Jingyi Zhang, Fangrong Yan, Nolan A Wages, Ruitao Lin
Local continual reassessment methods for dose finding and optimization in drug-combination trials. Statistical methods in medical research (2023)
Jia-Lin Meng, Aimin Jiang, Xiaofan Lu, Di Gu, Qintao Ge, Suwen Bai, Yundong Zhou, Jun Zhou, Zongyao Hao, Fangrong Yan, Linhui Wang, Haitao Wang, Juan Du, Chaozhao Liang
Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy. iMeta 2 (4) (2023)
Xiaofan Lu, Jia-Lin Meng, Junkai Zhu, Yujie Zhou, Liyun Jiang, Yang Wang, Weiheng Wen, Chaozhao Liang, Fangrong Yan
Prognosis stratification and personalized treatment in bladder cancer through a robust immune gene pair-based signature. Clinical and translational medicine 11 (6) (2022)
Liwen Su, Xin Chen, Jingyi Zhang, Fangrong Yan
Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials. JCO precision oncology 6 (2022)
Jia-Lin Meng, Xiaofan Lu, Chen Jin, Yujie Zhou, Qintao Ge, Jun Zhou, Zongyao Hao, Fangrong Yan, Meng Zhang, Chaozhao Liang
Integrated multi-omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer. Clinical and translational medicine 11 (12) (2022)
Xin Chen, Jingyi Zhang, Qian Jiang, Fangrong Yan
Borrowing historical information to improve phase I clinical trials using meta-analytic-predictive priors. Journal of biopharmaceutical statistics 32 (1) (2022)
Liwen Su, Xin Chen, Jingyi Zhang, Jun Gao, Fangrong Yan
Bayesian two-stage sequential enrichment design for biomarker-guided phase II trials for anticancer therapies. Biometrical journal. Biometrische Zeitschrift 64 (7) (2022)
Xiaofan Lu, Yann-Alexandre Vano, Alexandra Helleux, Xiaoping Su, Veronique Lindner, Guillaume Davidson, Roger Mouawad, Jean-Philippe Spano, Morgan Roupret, Reza-Thierry Elaidi, Eva M Comperat, Virginie Verkarre, Cheng-Ming Sun, Christine Chevreau, Mostefa Bennamoun, Hervé Lang, Thibault Tricard, Wenxuan Cheng, Li Xu, Irwin Davidson, Fangrong Yan, Wolf Herman Fridman, Catherine Sautès-Fridman, Stephane Marie Oudard, Gabriel G Malouf
An enhancer demethylator phenotype converged to immune dysfunction and resistance to immune checkpoint inhibitors in clear-cell renal cell carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Liwen Su, Jingyi Zhang, Fangrong Yan
An Adaptive Information Borrowing Platform Design for Testing Drug Candidates of COVID-19. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2022 (2022)
Xin Chen, Jingyi Zhang, Liyun Jiang, Fangrong Yan
Shotgun-2: A Bayesian phase I/II basket trial design to identify indication-specific optimal biological doses. Statistical methods in medical research (2022)
Xiaofan Lu, Jia-Lin Meng, Liwen Su, Liyun Jiang, Haitao Wang, Junkai Zhu, Mengjia Huang, Wenxuan Cheng, Li Xu, Xinjia Ruan, Shuyuan Yeh, Chaozhao Liang, Fangrong Yan
Multi-omics consensus ensemble refines the classification of muscle-invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies. Clinical and translational medicine 11 (12) (2022)
Lijing Ye, Jie Yang, Jingyi Li, Nannan Cheng, Yue Zhang, Xiaofan Lu, Ziyi Zhou, Zhuo Wang, Lishun Liu, Xiao Huang, Yun Song, Shibo Xing, Dongqing Wang, Junnong Li, Binyan Wang, Genfu Tang, Xianhui Qin, Pierre Zalloua, Huisheng Zhang, Fangrong Yan, Xiping Xu
Cigarette smoking and all-cause mortality in rural Chinese male adults: 15-year follow-up of the Anqing cohort study. BMC public health 21 (1) (2021)
Jing Pan, Yue Tan, Guoling Wang, Biping Deng, Zhuojun Ling, Weiliang Song, Samuel Seery, Yanlei Zhang, Shuixiu Peng, Jinlong Xu, Jiajia Duan, Zelin Wang, Xinjian Yu, Qinlong Zheng, Xiuwen Xu, Ying Yuan, Fangrong Yan, Zhenglong Tian, Kaiting Tang, Jiecheng Zhang, Alex H Chang, Xiaoming Feng
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (30) (2021)
Bosheng Li, Liwen Su, Yuqing Ye, Fangrong Yan
M&M: A maximum duration design with the Maxcombo test for a group sequential trial of an immunotherapy with a random delayed treatment effect. Statistics in medicine (2021)
Lin Liu, Junkai Zhu, Tong Jin, Mengjia Huang, Yi Chen, Li Xu, Wenxuan Chen, Bo Jiang, Fangrong Yan
Identification of Immune Function-Related Subtypes in Cutaneous Melanoma. Life (Basel, Switzerland) 11 (9) (2021)
Yizhou Hong, Liwen Su, Siyi Song, Fangrong Yan
Dynamic prediction of disease processes based on recurrent history and functional principal component analysis of longitudinal biomarkers: Application for ovarian epithelial cancer. Statistics in medicine 40 (8) (2021)
Bosheng Li, Liwen Su, Jun Gao, Liyun Jiang, Fangrong Yan
A group sequential design and sample size estimation for an immunotherapy trial with a delayed treatment effect. Statistical methods in medical research 30 (3) (2020)
Jia-Lin Meng, Xiaofan Lu, Yujie Zhou, Meng Zhang, Lei Gao, Shenglin Gao, Fangrong Yan, Chao-Zhao Liang
Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel-like factors in prostate cancer. Journal of cellular and molecular medicine 24 (10) (2020)
Nannan Cheng, Yue Zhang, Jie Yang, Jingyi Li, Lijing Ye, Ziyi Zhou, Zhuo Wang, Lishun Liu, Yun Song, Zhibo Yang, Guiping She, Xue Bai, Xiao Huang, Xiaoshu Cheng, Genfu Tang, Binyan Wang, Xianhui Qin, Pierre Zalloua, Fangrong Yan, Xiping Xu
Association Between Fasting Blood Glucose and All-Cause Mortality in a Rural Chinese Population: 15-Year Follow-Up Cohort Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 11 (11) (2020)
Xiaofan Lu, Yang Wang, Taige Chen, Jun Wang, Fangrong Yan
Classification of COVID-19 in intensive care patients. Critical care (London, England) 24 (1) (2020)
Xiaofan Lu, Yu-Jie Zhou, Jialin Meng, Liyun Jiang, Jun Gao, Yu Cheng, Hangyu Yan, Yang Wang, Bing Zhang, Xiaobo Li, Fangrong Yan
RNA processing genes characterize RNA splicing and further stratify colorectal cancer. Cell proliferation 53 (8) (2020)
Yang Wang, Xiaofan Lu, Yongsheng Li, Hui Chen, Taige Chen, Nan Su, Fang Huang, Jing Zhou, Bing Zhang, Fangrong Yan, Jun Wang
Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19. American journal of respiratory and critical care medicine 201 (11) (2020)
Xiaofan Lu, Yujie Zhou, Jialin Meng, Liyun Jiang, Jun Gao, Xiaole Fan, Yanfeng Chen, Yu Cheng, Yang Wang, Bing Zhang, Hangyu Yan, Fangrong Yan
Epigenetic age acceleration of cervical squamous cell carcinoma converged to human papillomavirus 16/18 expression, immunoactivation, and favourable prognosis. Clinical epigenetics 12 (1) (2020)
Xiaofan Lu, Liya Zhang, Huiling Zhao, Chen Chen, Yaoyan Wang, Shengjie Liu, Xiao Lin, Yue Wang, Qianyuan Zhang, Tao Lu, Fangrong Yan
Molecular classification and subtype-specific drug sensitivity research of uterine carcinosarcoma under multi-omics framework. Cancer biology & therapy 20 (2) (2018)
Xiaofan Lu, Qianyuan Zhang, Yue Wang, Liya Zhang, Huiling Zhao, Chen Chen, Yaoyan Wang, Shengjie Liu, Tao Lu, Fei Wang, Fangrong Yan
Molecular classification and subtype-specific characterization of skin cutaneous melanoma by aggregating multiple genomic platform data. Journal of cancer research and clinical oncology 144 (9) (2018)